Insights & News
Legal updates in the Russian Life Sciences industry for the first half of 2023
We are glad to present you with an overview of the Russian regulations in the sphere of pharmaceuticals and life sciences for the 1st half of 2023.
There are several digital initiatives ...
17 July 2023
Newsletters
Key changes in Life Sciences for the June-October 2022 period
We are glad to present you a current digest of the most significant bills, regulatory changes, and measures affecting the pharmaceutical and healthcare industry for the period from June t...
01 November 2022
Newsletters
Expanding compulsory licensing into Life Sciences industry
We would like to inform you that the Russian President has signed amendments to Article 1360 the Civil Code of the Russian Federation ('Russian Civil Code'), in terms of providing compuls...
20 May 2021
Newsletters
Head Start to 2021 for the Pharmaceutical Industry in Russia
We would like to inform you about several important news items, in the pharmaceutical industry, at the beginning of 2021.
The Rules of registration and assessment of medicines for medica...
11 February 2021
Newsletters
Blocking websites for non-compliance of healthcare regulations
On September 18th, 2020, the Federal Service for Surveillance in Healthcare (Roszdravnadzor) adopted a new Order approving the criteria for blocking the websites with the content infringi...
02 October 2020
Newsletters
Digital labelling of medications
As of July 1, the Russian requirements on digital labelling of medications and transmitting the data on medications’ turnover to the Chestny ZNAK system have become mandatory.
Start of m...
14 July 2020
Newsletters
Criminal antitrust investigations in Russian pharmaceutical and medical equipment markets
We would like to share our views on the latest trend in the criminal enforcement of the cartel crimes in the pharma and medical equipment markets.
Click here to download the file.
We ...
12 February 2020
Newsletters
Guidelines on advertising of over-the-counter (OTC) medicines
During 2017-2018, the Federal Antimonopoly Service of Russia (“FAS”) paid close attention to advertisements of OTC medicines and considered large number cases of violations of advertising...
14 January 2019
Newsletters